Lipid levels and their genetic regulation in patients with familial hypercholesterolemia and familial defective apolipoprotein B-100

The MEDPED Slovakia Project

Branislav Vohnout, Katarína Rašlová, Juraj Gašparovič, Jana Franeková, Lubomíra Fábryová, Martina Belošovičová, Gustáv Kováč, Claudia Šebová, Eva Rajecová, Jozef Stavný, Miron Babjak, Maria B. Donati, Licia Iacoviello

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We examined, from a cohort of 165 families, 529 individuals for familial hypercholesterolemia (FH). Utilising clinical criteria for diagnosis, we identified 122 patients (n=41 families) as having FH. With PCR testing, 31 individuals (n=12 families) were found to have familial defective Apo B-100 (FDB). From the cohort, 102 normolipidemic (NL) individuals served as a control group. Patients with FH had the highest levels of total cholesterol (TC), LDL-cholesterol (LDL-C) and apolipoprotein B (Apo B), followed by FDB patients and the normolipidemic relatives had the lowest levels (P

Original languageEnglish
Pages (from-to)3-5
Number of pages3
JournalAtherosclerosis Supplements
Volume4
Issue number3
DOIs
Publication statusPublished - Nov 2003

Fingerprint

Slovakia
Hyperlipoproteinemia Type II
Lipids
Apolipoprotein B-100
Apolipoproteins B
Hypercholesterolemia
LDL Cholesterol
Polymerase Chain Reaction
Control Groups

Keywords

  • Apo E
  • Familial defective Apo B-100
  • Familial hypercholesterolemia
  • Polymorphism

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lipid levels and their genetic regulation in patients with familial hypercholesterolemia and familial defective apolipoprotein B-100 : The MEDPED Slovakia Project. / Vohnout, Branislav; Rašlová, Katarína; Gašparovič, Juraj; Franeková, Jana; Fábryová, Lubomíra; Belošovičová, Martina; Kováč, Gustáv; Šebová, Claudia; Rajecová, Eva; Stavný, Jozef; Babjak, Miron; Donati, Maria B.; Iacoviello, Licia.

In: Atherosclerosis Supplements, Vol. 4, No. 3, 11.2003, p. 3-5.

Research output: Contribution to journalArticle

Vohnout, B, Rašlová, K, Gašparovič, J, Franeková, J, Fábryová, L, Belošovičová, M, Kováč, G, Šebová, C, Rajecová, E, Stavný, J, Babjak, M, Donati, MB & Iacoviello, L 2003, 'Lipid levels and their genetic regulation in patients with familial hypercholesterolemia and familial defective apolipoprotein B-100: The MEDPED Slovakia Project', Atherosclerosis Supplements, vol. 4, no. 3, pp. 3-5. https://doi.org/10.1016/S1567-5688(03)00023-0
Vohnout, Branislav ; Rašlová, Katarína ; Gašparovič, Juraj ; Franeková, Jana ; Fábryová, Lubomíra ; Belošovičová, Martina ; Kováč, Gustáv ; Šebová, Claudia ; Rajecová, Eva ; Stavný, Jozef ; Babjak, Miron ; Donati, Maria B. ; Iacoviello, Licia. / Lipid levels and their genetic regulation in patients with familial hypercholesterolemia and familial defective apolipoprotein B-100 : The MEDPED Slovakia Project. In: Atherosclerosis Supplements. 2003 ; Vol. 4, No. 3. pp. 3-5.
@article{2a227290dc794056b48c42df87e77244,
title = "Lipid levels and their genetic regulation in patients with familial hypercholesterolemia and familial defective apolipoprotein B-100: The MEDPED Slovakia Project",
abstract = "We examined, from a cohort of 165 families, 529 individuals for familial hypercholesterolemia (FH). Utilising clinical criteria for diagnosis, we identified 122 patients (n=41 families) as having FH. With PCR testing, 31 individuals (n=12 families) were found to have familial defective Apo B-100 (FDB). From the cohort, 102 normolipidemic (NL) individuals served as a control group. Patients with FH had the highest levels of total cholesterol (TC), LDL-cholesterol (LDL-C) and apolipoprotein B (Apo B), followed by FDB patients and the normolipidemic relatives had the lowest levels (P",
keywords = "Apo E, Familial defective Apo B-100, Familial hypercholesterolemia, Polymorphism",
author = "Branislav Vohnout and Katar{\'i}na Rašlov{\'a} and Juraj Gašparovič and Jana Franekov{\'a} and Lubom{\'i}ra F{\'a}bryov{\'a} and Martina Belošovičov{\'a} and Gust{\'a}v Kov{\'a}č and Claudia Šebov{\'a} and Eva Rajecov{\'a} and Jozef Stavn{\'y} and Miron Babjak and Donati, {Maria B.} and Licia Iacoviello",
year = "2003",
month = "11",
doi = "10.1016/S1567-5688(03)00023-0",
language = "English",
volume = "4",
pages = "3--5",
journal = "Atherosclerosis Supplements",
issn = "1567-5688",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Lipid levels and their genetic regulation in patients with familial hypercholesterolemia and familial defective apolipoprotein B-100

T2 - The MEDPED Slovakia Project

AU - Vohnout, Branislav

AU - Rašlová, Katarína

AU - Gašparovič, Juraj

AU - Franeková, Jana

AU - Fábryová, Lubomíra

AU - Belošovičová, Martina

AU - Kováč, Gustáv

AU - Šebová, Claudia

AU - Rajecová, Eva

AU - Stavný, Jozef

AU - Babjak, Miron

AU - Donati, Maria B.

AU - Iacoviello, Licia

PY - 2003/11

Y1 - 2003/11

N2 - We examined, from a cohort of 165 families, 529 individuals for familial hypercholesterolemia (FH). Utilising clinical criteria for diagnosis, we identified 122 patients (n=41 families) as having FH. With PCR testing, 31 individuals (n=12 families) were found to have familial defective Apo B-100 (FDB). From the cohort, 102 normolipidemic (NL) individuals served as a control group. Patients with FH had the highest levels of total cholesterol (TC), LDL-cholesterol (LDL-C) and apolipoprotein B (Apo B), followed by FDB patients and the normolipidemic relatives had the lowest levels (P

AB - We examined, from a cohort of 165 families, 529 individuals for familial hypercholesterolemia (FH). Utilising clinical criteria for diagnosis, we identified 122 patients (n=41 families) as having FH. With PCR testing, 31 individuals (n=12 families) were found to have familial defective Apo B-100 (FDB). From the cohort, 102 normolipidemic (NL) individuals served as a control group. Patients with FH had the highest levels of total cholesterol (TC), LDL-cholesterol (LDL-C) and apolipoprotein B (Apo B), followed by FDB patients and the normolipidemic relatives had the lowest levels (P

KW - Apo E

KW - Familial defective Apo B-100

KW - Familial hypercholesterolemia

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=10744233946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744233946&partnerID=8YFLogxK

U2 - 10.1016/S1567-5688(03)00023-0

DO - 10.1016/S1567-5688(03)00023-0

M3 - Article

VL - 4

SP - 3

EP - 5

JO - Atherosclerosis Supplements

JF - Atherosclerosis Supplements

SN - 1567-5688

IS - 3

ER -